Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sex-linked Disorders

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Gonadal and Placental Hormones

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...

Sex Linked Disorders

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

Hypothalamic-Pituitary Axis

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Exocrine pancreatic insufficiency and Turner syndrome: a pediatric case report].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015

Same author

Four-flux model for a multilayer, plane absorbing and scattering medium: application to the optical degradation of white paint in a space environment.

Applied optics·2008

Same author

Comparison of iterative and monte carlo methods for calculation of the Aureole about a point source in the earth's atmosphere.

Applied optics·2008

Same author

Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest.

Molecular and cellular endocrinology·2003

Same author

Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons.

The Journal of pharmacology and experimental therapeutics·2003

Same author

[Management of central precocious puberty].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2003

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Dual Somatic Recordings from Gonadotropin-Releasing Hormone (GnRH) Neurons Identified by Green Fluorescent Protein (GFP) in Hypothalamic Slices

Dual Somatic Recordings from Gonadotropin-Releasing Hormone (GnRH) Neurons Identified by Green Fluorescent Protein (GFP) in Hypothalamic Slices

Published on: February 23, 2010

[Congenital hypogonadotropic hypogonadism].

C Roze¹, P Touraine, J Leger

¹Inserm U690, hôpital Robert-Debré, 75019 Paris, France.

Annales D'Endocrinologie

|February 10, 2009

Summary

Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder caused by low LH and FSH secretion, leading to reduced sex hormone production. Diagnosis and treatment are crucial for puberty induction, hormonal replacement, and fertility management in affected individuals.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

Dual Somatic Recordings from Gonadotropin-Releasing Hormone (GnRH) Neurons Identified by Green Fluorescent Protein (GFP) in Hypothalamic Slices

Dual Somatic Recordings from Gonadotropin-Releasing Hormone (GnRH) Neurons Identified by Green Fluorescent Protein (GFP) in Hypothalamic Slices

Published on: February 23, 2010

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Area of Science:

Endocrinology
Reproductive Medicine
Genetics

Background:

Congenital hypogonadotropic hypogonadism (CHH) is characterized by insufficient secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
This deficiency results in impaired steroid hormone synthesis and secretion, impacting sexual development and reproduction.
The prevalence of CHH is estimated at approximately 1 in 5000 births, highlighting its rarity.

Purpose of the Study:

To define congenital hypogonadotropic hypogonadism, its causes, and diagnostic considerations.
To outline the genetic basis and molecular studies relevant to CHH diagnosis.
To describe the recommended treatment strategies for CHH, including puberty induction and hormonal therapy.

Main Methods:

Diagnosis is based on clinical presentation, including micropenis at birth, delayed or absent puberty during adolescence, and infertility in adulthood.
Evaluation involves assessing the hypothalamopituitary axis function and identifying potential defects in GnRH neuron migration or pituitary development.
Molecular studies are recommended to identify specific gene defects, aiding in diagnosis and genetic counseling.

Main Results:

CHH can manifest as an isolated defect of the gonadotropic axis or be associated with other endocrine disorders or complex syndromes.
Several gene defects underlying CHH have been identified, providing insights into its pathogenesis.
Treatment involves timely intervention with therapies to induce puberty and maintain hormonal balance throughout adulthood.

Conclusions:

Early diagnosis and management of CHH are essential for achieving normal sexual development and reproductive function.
Genetic testing plays a vital role in confirming the diagnosis and providing accurate genetic counseling.
Hormonal replacement therapy and specific infertility treatments are key components of CHH management, with consideration for potential transmission risks in dominant forms.